These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38779018)

  • 1. Poria acid inhibit the growth and metastasis of renal cell carcinoma by inhibiting the PI3K/akt/NF-κb signaling pathway.
    Yang H; Zhao Y; Ren B; Wu Y; Qiu Z; Cheng Y; Qiu B
    Heliyon; 2024 May; 10(10):e31106. PubMed ID: 38779018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Root extract of Hemsleya amabilis Diels suppresses renal cell carcinoma cell growth through inducing apoptosis and G
    Li K; You G; Jiang K; Wang R; Li W; Meng Y; Fang Y; Chen W; Zhu G; Song J; Wang W; Su H; Hu B; Sun F; Jia Z; Li C; Zhu J
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117014. PubMed ID: 37557938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway.
    Qu J; Li J; Zhang Y; He R; Liu X; Gong K; Duan L; Luo W; Hu Z; Wang G; Xia C; Luo D
    Cell Biosci; 2021 Aug; 11(1):163. PubMed ID: 34419144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrandrine inhibits migration and invasion of human renal cell carcinoma by regulating Akt/NF-κB/MMP-9 signaling.
    Chen S; Liu W; Wang K; Fan Y; Chen J; Ma J; Wang X; He D; Zeng J; Li L
    PLoS One; 2017; 12(3):e0173725. PubMed ID: 28288190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive triterpenoid compounds of Poria cocos (Schw.) Wolf in the treatment of diabetic ulcers via regulating the PI3K-AKT signaling pathway.
    Ding X; Li S; Huang H; Shen J; Ding Y; Chen T; Ma L; Liu J; Lai Y; Chen B; Wang Y; Tan Q
    J Ethnopharmacol; 2024 May; 325():117812. PubMed ID: 38301984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ampelopsin Inhibits Cell Viability and Metastasis in Renal Cell Carcinoma by Negatively Regulating the PI3K/AKT Signaling Pathway.
    Zhao Z; Jiang Y; Liu Z; Li Q; Gao T; Zhang S
    Evid Based Complement Alternat Med; 2021; 2021():4650566. PubMed ID: 34804180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN.
    Deng W; Han W; Fan T; Wang X; Cheng Z; Wan B; Chen J
    Biomed Pharmacother; 2018 Nov; 107():1505-1513. PubMed ID: 30257368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
    Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
    Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C₁₈H₁₇NO₆ Inhibits Invasion and Migration of Human MNNG Osteosarcoma Cells via the PI3K/AKT Signaling Pathway.
    Qu Q; He Z; Jiang Y; Lu D; Long X; Ding Y; Xu B; He X
    Med Sci Monit; 2019 Oct; 25():7527-7537. PubMed ID: 31589596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
    Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma
    Lin H; Zeng W; Lei Y; Chen D; Nie Z
    Pathol Oncol Res; 2021; 27():640936. PubMed ID: 34257606
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Yang B; Wang B; Wang G; Cao W; Wang Q; Pu H; An W
    Anticancer Agents Med Chem; 2023; 23(13):1577-1586. PubMed ID: 37139674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of Tescalcin inhibits growth and metastasis in renal cell carcinoma via downregulating NHE1 and NF-kB signaling.
    Luo AJ; Tan J; He LY; Jiang XZ; Jiang ZQ; Zeng Q; Yao K; Xue J
    Exp Mol Pathol; 2019 Apr; 107():110-117. PubMed ID: 30594602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astaxanthin suppresses the malignant behaviors of nasopharyngeal carcinoma cells by blocking PI3K/AKT and NF-κB pathways via miR-29a-3p.
    Xu Y; Jiang C
    Genes Environ; 2024 Apr; 46(1):10. PubMed ID: 38649975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
    Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
    Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-elemene Suppresses Migration of Esophageal Squamous Cell Carcinoma by Modulating Expression of MMP9 through the PI3K/Akt/NF-κB Pathway.
    Liang Y; Li S
    Comb Chem High Throughput Screen; 2023; 26(13):2304-2320. PubMed ID: 36872359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of miR-21 on Apoptosis in Lung Cancer Cell Through Inhibiting the PI3K/ Akt/NF-κB Signaling Pathway in Vitro and in Vivo.
    Zhou B; Wang D; Sun G; Mei F; Cui Y; Xu H
    Cell Physiol Biochem; 2018; 46(3):999-1008. PubMed ID: 29669316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells
    Yang H; Li H; Lu S; Shan S; Guo Y
    Biomed Res Int; 2022; 2022():5739909. PubMed ID: 35281608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway.
    Shen T; Yang Z; Cheng X; Xiao Y; Yu K; Cai X; Xia C; Li Y
    Oncol Rep; 2017 Apr; 37(4):2095-2100. PubMed ID: 28259918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.